Co-Authors
This is a "connection" page, showing publications co-authored by Ruth Harvey and Saira Hussain.
Connection Strength
0.589
-
Favorable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseases. Med (N Y). 2021 Sep 10; 2(9):1093-1109.e6.
Score: 0.060
-
Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients. Lancet. 2021 09 18; 398(10305):1038-1041.
Score: 0.060
-
Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains. Elife. 2021 07 29; 10.
Score: 0.060
-
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase. Biochem J. 2021 07 16; 478(13):2405-2423.
Score: 0.060
-
AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC. Lancet. 2021 07 17; 398(10296):207-209.
Score: 0.060
-
Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination. Lancet. 2021 06 19; 397(10292):2331-2333.
Score: 0.059
-
Breadth and function of antibody response to acute SARS-CoV-2 infection in humans. PLoS Pathog. 2021 02; 17(2):e1009352.
Score: 0.058
-
A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses. Nat Commun. 2021 01 22; 12(1):542.
Score: 0.058
-
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans. Science. 2020 12 11; 370(6522):1339-1343.
Score: 0.057
-
Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein. Nat Commun. 2020 10 21; 11(1):5337.
Score: 0.057